Drug resistance and in vitro susceptibility of Plasmodium falciparum in Thailand during 1988-2003

Korean Journal of Parasitology

Volumn 47, Issue 2, 2009, Pages 139-144

  Suwandittakul, Nantana ^a   Chaijaroenkul, Wanna ^a   Harnyuttanakorn, Pongchai ^b   Mungthin, Mathirut ^c   Na Bangchang, Kesara ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c PHRAMONGKUTKLAO HOSPITAL   (Thailand)

Author keywords

Drug pressure; In vitro testing; Rasmodium falciparum; Thailand

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; ARTESUNATE PLUS MEFLOQUINE; CHLOROQUINE; FANSIMEF; HYPOXANTHINE; MEFLOQUINE; QUININE; TRITIUM; UNCLASSIFIED DRUG; ARTEMISININ DERIVATIVE;

ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG EFFICACY; DRUG USE; IC 50; IN VITRO STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PARASITE ISOLATION; PHENOTYPIC VARIATION; PLASMODIUM FALCIPARUM; THAILAND; ANIMAL; DRUG EFFECT; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN; ISOLATION AND PURIFICATION; MALARIA; METHODOLOGY; PARASITOLOGY;

ARTESUNATE; PLASMODIUM FALCIPARUM;

ANIMALS; ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; DRUG RESISTANCE; HUMANS; MALARIA; MEFLOQUINE; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; QUININE; THAILAND;

EID: 67649985939     PISSN: 00234001     EISSN: 17380006     Source Type: Journal    
DOI: 10.3347/kjp.2009.47.2.139     Document Type: Article

References (19)

1. Harinasuta T, Suntharasamai P, Viravan C. Chloroquine-resistant falciparum malaria in Thailand. Lancet 1965; 2: 657-660.
2. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR. Epidemiology of drug-resistant malaria. Lancet Infect Dis 2002; 2: 209-218.
3. Escalante AA, Cornejo OE, Rojas A, Udhayakumar V, Lal AA. Assessing the effect of natural selection in malaria parasites. Trends Parasitol 2004; 20: 388-395.
4. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science 1976; 193: 673-675.
5. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 1979; 16: 710-718.
6. Cerutti Jr C, Marques AC, de Alencar FE, Durlacher RR, Alween A, Segurado AA, Pang L, Zalis MG. Antimalarial drug susceptibility testing of Plasmodium falciparum in Brazil using a radioisotope method. Mem Inst Oswaldo Cruz 1999; 94: 803-809.
7. Pickard AL, Wongsrichanalai C, Purfield A, Kamwendo D, Emery K, Zalewski C, Kawamoto F, Miller RS, Meshnick SR. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr 1. Antimicrob Agents Chemother 2003; 47: 2418-2423.
8. Chaijaroenkul W, Bangchang KN, Mungthin M, Ward SA. In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003. Malaria J 2005; 4: 37.
9. Laufer MK, Plowe CV. Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies. Drug Resist Update 2004; 7: 279-288.
10. Laufer MK, van Oosterhout JJ, Thesing PC, Thumba F, Zijlstra EE, Graham SM, Taylor TE, Plowe CV. Impact of HIV-associated immunosuppression on malaria infection and disease in Malawi. J Infect Dis 2006; 193: 872-878.
11. Lim P, Chim P, Sem R, Nemh S, Poravuth Y, Lim C, Seila S, Tsuyuoka R, Denis MB, Socheat D, Fandeur T. In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002. Acta Trop 2005; 93: 31-40.
12. Looareesuwan S, Kyle DE, Viravan C, Vanijanonta S, Wilairatana P, Charoenlarp P, Canfield CJ, Webster HK. Treatment of patients with recrudescent falciparum malaria with a sequential combination of artesunate and mefloquine. Am J Trop Med Hyg 1992; 47: 794-799.
13. McGready R, Brockman A, Cho T, Cho D, van Vugt M, Luxemburger C, Chongsuphajaisiddhi T, White NJ, Nosten F. Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 2000; 94: 689-693.
14. Pukrittayakamee S, Wanwimolruk S, Stepniewska K, Jantra A, Huyakorn S, Looareesuwan S, White NJ. Quinine pharmacokinetic-pharmacodynamic relationships in uncomplicated falciparum malaria. Antimicrob Agents Chemother 2003; 47: 3458-3463.
15. Vijaykadga S, Rojanawatsirivej C, Cholpol S, Phoungmanee D, Nakavej A, Wongsrichanalai C. In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop Med Int Health 2006; 11: 211-219.
16. White N. Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc Lond B Biol Sci 1999; 354: 739-749.
17. Cowman AF, Galatis D, Thompson JK. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr 1 gene and cross-resistance to halofantrine and quinine. Proc Natl Acad Sci USA 1994; 91: 1143-1147.
18. Suebsaeng L, Wernsdorfer WH, Rooney W. Sensitivity to quinine and mefloquine of Plasmodium falciparum in Thailand. Bull WHO 196; 64: 759-765.
19. Wilson CM, Volkman SK, Thaithong S, Martin RK, Kyle DE, Milhous WK, Wirth DF. Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol Biochem Parasitol 1993; 57: 151-160.